Crucell (CRXLY) Company Profile

Crucell (CRXLY) Company Profile

Last Updated by Anonymous | Update This Page Now

►Summary | Profile | News | Chart | SWOT | Cash Flow | Comps | Buffett | WACC

General Information

Name:
Website:
Phone: n/a
Email: n/a
Founded: n/a
Employees: n/a
Stage: Seed (just an idea)
Location:

Address:
n/a

Industry / Market

Target:
Products: n/a
Size: n/a
Growth Rate: n/a%
Other Info: n/a

Management Team
Multi-Media

Web Presence
n/a

Images:

Documents:

Videos:

Crucell N.V. is a biopharmaceutical company focused on developing and producing products to combat infectious diseases in three distinct areas: pediatric, travel and endemic, and respiratory. Crucells product development programs include vaccines against yellow fever, influenza, human immunodeficiency virus (HIV), malaria, tuberculosis, human monoclonal antibodies against rabies, H5N1 antibodies, pandemic influenza virus, as well as blood coagulation factors. (see report summary)


Management Analysis Update

has a consistent company strategy. Big strategy changes can be disruptive, which could hurt long term value.


Milestones Update


Click here to see 's Discounted Cash Flow analysis.

Discuss

Add a New Comment
or Sign in as Wikidot user
(will not be published)
- +